Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis
Journal of Leukocyte Biology · 08.06.2026 · 118 (6)
DOI: 10.1093/jleuko/qiag057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 30.06.2026. Verfasst von Timothy Arthur Chandos Snow und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, Gower Street, London, WC1E 6BT, United Kingdom. Hauptthemen laut MEDLINE: Interleukin-7, Sepsis, Nivolumab, Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Medical Research Council, RCoA/BJA Project Award, University College London.
Themen: Sepsis
Abstract (Originalsprache)
Therapeutic modulation of sepsis-induced immune dysfunction by targeting lymphocyte dysfunction with recombinant IL-7 (rIL-7) and anti-PD-1 (e.g. nivolumab) has shown promise in preclinical and early clinical studies. Prior to conducting large randomized controlled trials, an in-depth understanding of the changes induced by rIL-7 or nivolumab (and their differences) in patients with sepsis is imperative. We performed a prospective observational cohort study including patients admitted to the intensive care unit with sepsis and characterized their T lymphocyte phenotype using flow cytometry. The ability of T lymphocytes to respond to a stimulus (using anti-CD3/CD28 beads) and the effect of rIL-7 or nivolumab on T lymphocyte immunophenotype ex vivo was assessed. In a cohort of 55 patients, CD4+ and CD8+ T lymphocyte PD-1 was higher and IL-7R lower compared with healthy volunteers. In a subset of 24 intensive care unit patients in whom in-depth immunophenotype was characterized, ex vivo response of lymphocytes to anti-CD3/CD28 beads was reduced compared with healthy volunteers, simultaneously inducing features consistent with immune activation and immunosuppression. rIL-7 was associated with a greater spectrum of changes compared with nivolumab. The response to rIL-7 and nivolumab was influenced by anti-CD3/CD28 bead costimulation. rIL-7 and nivolumab elicited distinct T lymphocyte responses ex vivo, and the changes were influenced by T lymphocyte activation. It needs to be determined if similar changes occur in vivo, which may influence the choice of immunomodulatory therapy in sepsis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, Gower Street, London, WC1E 6BT, United Kingdom.
- Centre for Anaesthesia, Critical Care & Pain Medicine, Department of Targeted Intervention, University College London, Gower Street, London, WC1E 6BT, United Kingdom.
- Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, Strand, London, WC2R 2LS, United Kingdom.
- Division of Infection and Immunity, University College London, Gower Street, London, WC1E 6BT, United Kingdom.
- UCLH NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, Euston Road, London, NW1 2BU, United Kingdom.
ORCID-Profile: Timothy Arthur Chandos Snow, Caroline Copeland, Mervyn Singer
Förderung
- UK Medical Research Council
- RCoA/BJA Project Award
- University College London
- European Society of Intensive Care Medicine
- UCLH NIHR Biomedical Research Centre
Zitieren
APA
Snow, T. A. C., Pisciotta, W., Martir, G., Copeland, C., Sekeris, A., Das, A., Singer, M., Brealey, D., & Arulkumaran, N. (2026). Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis. Journal of Leukocyte Biology, 118(6). https://doi.org/10.1093/jleuko/qiag057
Vancouver
Snow TAC, Pisciotta W, Martir G, Copeland C, Sekeris A, Das A, et al. Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis. Journal of Leukocyte Biology. 2026;118(6). doi:10.1093/jleuko/qiag057
BibTeX
@article{Snow2026,
author = {Snow, Timothy Arthur Chandos and Pisciotta, Walter and Martir, Gladys and Copeland, Caroline and Sekeris, Athanasios and Das, Abhishek and Singer, Mervyn and Brealey, David and Arulkumaran, Nishkantha},
title = {Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis},
journal = {Journal of Leukocyte Biology},
year = {2026},
volume = {118},
number = {6},
doi = {10.1093/jleuko/qiag057}
}
EUVIMED